Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR292833 in chronic peripheral neuropathic pain
2011-001876-21Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain comparing SAR292833 with Placebo (2 arms). Primary endpoint: Change from baseline to week 4 in average daily pain intensity. Started Oct 2011; status: completed.
02
Drugs
GRC-15300
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on 2011-001876-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001876-21.